Aktiv Pharma Group receives grant funding to develop tranexamic acid autoinjector : vimarsana.com

Broomfield, Colorado (PRWEB) June 27, 2022 -- Aktiv Pharma Group (Aktiv) announced today a grant award from the U.S. Department of Defense (DOD) Defense

Related Keywords

Colorado , United States , Amir Genosar , Philip Charles , Us Department Of Defense , Cu Center , Biotechnology Advanced Research , Department Of Emergency Medicine , Us Army Medical Research Acquisition Activity , Research Lab , University Of Colorado School Medicine , Casualty Care Research Program , Aktiv Pharma Group , Defense Health Agency , Department Of Agriculture , Us Army Medical Research , Human Services , Us Department Of Health , Drug Administration , Development Authority , Program Committee , Health Affairs , Office Of The , Development Command Under Award No , Pharma Group , Joint Program Committee , Combat Casualty Care Research Program , Colorado School , Combat Medicine , Vik Bebarta , Emergency Medicine , Good Manufacturing Practice , Assistant Secretary , Medical Research , Development Command , Medical Research Acquisition Activity , Fort Detrick , Press Release ,